Search

Your search keyword '"Tumor Suppressor Protein p53 genetics"' showing total 27,638 results

Search Constraints

Start Over You searched for: Descriptor "Tumor Suppressor Protein p53 genetics" Remove constraint Descriptor: "Tumor Suppressor Protein p53 genetics"
27,638 results on '"Tumor Suppressor Protein p53 genetics"'

Search Results

1. The mitochondrial enzyme pyruvate carboxylase restricts pancreatic β-cell senescence by blocking p53 activation.

2. Loss of myosin light chain kinase induces the cellular senescence associated secretory phenotype to promote breast epithelial cell migration.

3. Discovery of petroleum ether extract of eclipta targeting p53/Fas pathway for the treatment of chemotherapy-induced alopecia: Network pharmacology and experimental validation.

4. The pluripotent-to-totipotent state transition in mESCs activates the intrinsic apoptotic pathway through DUX-induced DNA replication stress.

5. p53 terminates the regenerative fetal-like state after colitis-associated injury.

6. Temporal regulation of gene expression through integration of p53 dynamics and modifications.

7. Peptidyl arginine deiminase-4 inhibitor ameliorates pulmonary fibrosis through positive regulation of developmental endothelial locus-1.

8. SASS6 promotes tumor proliferation and is associated with TP53 and immune infiltration in lung adenocarcinoma.

9. Enhanced SIRT1 Activity by Galangin Mitigates UVB-Induced Senescence in Dermal Fibroblasts via p53 Acetylation Regulation and Activation.

10. High prevalence of chromosome 17 in breast cancer micronuclei: a means to get rid of tumor suppressors?

11. Modeling NK-cell lymphoma in mice reveals its cell-of-origin and microenvironmental changes and identifies therapeutic targets.

12. Epstein-Barr virus replication within differentiated epithelia requires pRb sequestration of activator E2F transcription factors.

13. Hallmarks of a genomically distinct subclass of head and neck cancer.

14. The deubiquitinase OTUD3 stabilizes IRP2 expression to reduce hippocampal neuron ferroptosis via the p53/PTGS2 pathway to ameliorate cerebral ischemia-reperfusion injury.

15. Inactive Parp2 causes Tp53-dependent lethal anemia by blocking replication-associated nick ligation in erythroblasts.

16. Influence of TP53 gene mutations and their allelic status in myelodysplastic syndromes with isolated 5q deletion.

17. Genome-wide RNA-Seq identifies TP53-mediated embryonic stem cells inhibiting tumor invasion and metastasis.

18. AR expression-independent XRCC3 mediates DNA damage-induced p53/Bax signaling pathway activation against prostate cancer.

19. [Multi-gene mutations in ultrasound-guided fine-needle aspiration specimens of thyroid micronodules and diagnostic value in thyroid microcarcinomas using next-generation sequencing].

20. Loss of NAT10 Reduces the Translation of Kmt5a mRNA Through ac4C Modification in Cardiomyocytes and Induces Heart Failure.

21. CDK12 loss drives prostate cancer progression, transcription-replication conflicts, and synthetic lethality with paralog CDK13.

22. Genomic Landscape and Clinical Features of Advanced Thyroid Carcinoma: A National Database Study in Japan.

23. The Impact of Li-Fraumeni and Germline Retinoblastoma Mutations on Leiomyosarcoma Initiation, Outcomes, and Genetic Testing Recommendations.

24. The role of p53 in male infertility.

25. FBXO family genes promotes hepatocellular carcinoma via ubiquitination of p53.

26. Myeloid cannabinoid CB1 receptor deletion confers atheroprotection in male mice by reducing macrophage proliferation in a sex-dependent manner.

27. Deletion of Slc1a4 Suppresses Single Mauthner Cell Axon Regeneration In Vivo through Growth-Associated Protein 43.

28. Trp53 Deletion Promotes Exacerbated Colitis, Facilitates Lgr5+ Cancer Stem Cell Expansion, and Fuels Tumorigenesis in AOM/DSS-Induced Colorectal Cancer.

29. TP53 mutation status and consensus molecular subtypes of colorectal cancer in patients from Rwanda.

30. Targeting mutant p53: a key player in breast cancer pathogenesis and beyond.

31. Optimizing drug combinations for T-PLL: restoring DNA damage and P53-mediated apoptotic responses.

32. FUSE: Improving the estimation and imputation of variant impacts in functional screening.

33. [Advances in molecular characteristics of pediatric meningiomas].

34. Negative feedback loop in the activation of non-homologous end joining DNA repair pathway in Helicobacter pylori infected patients with gastritis.

35. MAD1 upregulation sensitizes to inflammation-mediated tumor formation.

36. Predicting p53-dependent cell transitions from thermodynamic models.

37. Impact of molecular classification on recurrence risk in endometrial cancer patients with lymph node metastasis: multicenter retrospective study.

38. Circulating tumour DNA in patients with hepatocellular carcinoma across tumour stages and treatments.

39. Pre-ciliated tubal epithelial cells are prone to initiation of high-grade serous ovarian carcinoma.

40. Disruption of NADPH homeostasis by total flavonoids from Adinandra nitida Merr. ex Li leaves triggers ROS-dependent p53 activation leading to apoptosis in non-small cell lung cancer cells.

41. Differential effect of plakoglobin in restoring the tumor suppressor activities of p53-R273H vs. p53-R175H mutants.

42. Phage libraries screening on P53: Yield improvement by zinc and a new parasites-integrating analysis.

43. CRISPR-mediated ablation of TP53 and EGFR mutations enhances gefitinib sensitivity and anti-tumor efficacy in lung cancer.

44. Zebrafish reveal new roles for Fam83f in hatching and the DNA damage-mediated autophagic response.

45. The N-terminal fragment of histone deacetylase 4 (1-669aa) promotes chondrocyte apoptosis via the p53-dependent endoplasmic reticulum stress pathway.

46. Establishment and Characterization of a Novel Pleuropulmonary Blastoma Cell Line.

47. Upfront Management of Blastoid Variant Mantle Cell Lymphoma: Making the Case for 2nd/3rd-Generation Bruton Tyrosine Kinase Inhibitor-Based Therapies.

48. Haploidy-linked cell proliferation defects limit larval growth in zebrafish.

49. Transplant or no transplant for TP53 mutated AML.

50. Distinct landscape and clinical implications of therapy-related clonal hematopoiesis.

Catalog

Books, media, physical & digital resources